Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Seidman

Showing results (11-20 of 89) with videos related to

Pageof 9
Sort By:
Nature Clinical Practice. Oncology|April 6, 2006
Is trastuzumab active following conventional adjuvant chemotherapy in HER2-positive early breast cancer?Andrew D Seidman
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2013
New advances in taxane therapy: the next generationAndrew D Seidman
Seminars in Oncology|December 10, 2003
Cardiac effects of adjuvant therapy for early breast cancerMaria Theodoulou, Andrew D Seidman
Cancer Treatment and Research|January 4, 2024
Breast Cancer Brain Metastases: Achilles' Heel in Breast Cancer Patients' CareEmanuela Ferraro, Andrew D Seidman
NPJ Breast Cancer|August 21, 2019
Adjuvant chemotherapy for node negative, high Recurrence Score<sup>TM</sup> breast cancer: in defense of de-escalationDiana Lake, Andrew D Seidman
Clinical Breast Cancer|February 3, 2004
Single-agent gemcitabine in the treatment of advanced breast cancerShanu Modi, Andrew D Seidman
Current Oncology Reports|December 6, 2001
An update on epidermal growth factor receptor inhibitorsShanu Modi, Andrew D Seidman
The Oncologist|November 28, 2002
Incorporating oral capecitabine into the treatment of breast cancer. IntroductionAndrew D Seidman, Matti Aapro
Cancer Treatment Reviews|September 16, 2003
Dose-dense treatment prolongs disease-free survival of women with node positive breast cancerChau Dang, Andrew D Seidman
Current Oncology Reports|December 22, 2004
Two regimens of docetaxel for metastatic breast cancerAndrew D Seidman, Larry Norton
Pageof 9

Showing results (11-20 of 89) with videos related to

Sort By:
Pageof 9
Nature Clinical Practice. Oncology|April 6, 2006
Is trastuzumab active following conventional adjuvant chemotherapy in HER2-positive early breast cancer?Andrew D Seidman
Journal of the National Comprehensive Cancer Network : JNCCN|April 11, 2013
New advances in taxane therapy: the next generationAndrew D Seidman
Seminars in Oncology|December 10, 2003
Cardiac effects of adjuvant therapy for early breast cancerMaria Theodoulou, Andrew D Seidman
Cancer Treatment and Research|January 4, 2024
Breast Cancer Brain Metastases: Achilles' Heel in Breast Cancer Patients' CareEmanuela Ferraro, Andrew D Seidman
NPJ Breast Cancer|August 21, 2019
Adjuvant chemotherapy for node negative, high Recurrence Score<sup>TM</sup> breast cancer: in defense of de-escalationDiana Lake, Andrew D Seidman
Clinical Breast Cancer|February 3, 2004
Single-agent gemcitabine in the treatment of advanced breast cancerShanu Modi, Andrew D Seidman
Current Oncology Reports|December 6, 2001
An update on epidermal growth factor receptor inhibitorsShanu Modi, Andrew D Seidman
The Oncologist|November 28, 2002
Incorporating oral capecitabine into the treatment of breast cancer. IntroductionAndrew D Seidman, Matti Aapro
Cancer Treatment Reviews|September 16, 2003
Dose-dense treatment prolongs disease-free survival of women with node positive breast cancerChau Dang, Andrew D Seidman
Current Oncology Reports|December 22, 2004
Two regimens of docetaxel for metastatic breast cancerAndrew D Seidman, Larry Norton
Pageof 9